Among Australian youth seeking mental healthcare, those with a diagnosed substance use disorder reported more severe depression, anxiety, and higher frequency cannabis use than those who used substances without meeting disorder criteria.
Youth mental health clinicians, early intervention researchers, substance use disorder specialists
SUD-diagnosed youth had higher risk scores across 6 substance categories
What the researchers found
Comparing 51 youth with a current SUD to 21 without a lifetime SUD diagnosis, those with SUD endorsed more severe depressive and anxiety symptoms, lower quality of life and role functioning, more alcohol-related problems, and higher frequency cannabis use. They also had higher risk scores for alcohol, tobacco, cannabis, cocaine, amphetamines, and hallucinogens. No group differences emerged for social/occupational functioning or subjectively rated sleep quality.
Why it matters
Youth mental health services frequently encounter substance use but may not distinguish between use and disorder. This study shows the clinical gap between the two is substantial, with SUD-diagnosed youth carrying heavier psychiatric and functional burdens that require integrated treatment approaches.
The numbers in context
n=79 (51 with current SUD, 21 without lifetime SUD); ages 12-25; SUD group had higher frequency cannabis use and higher risk scores across 6 substance categories; no differences in social/occupational functioning or sleep
How the study worked
Baseline data from the INTEGRATE clinical trial. 79 participants aged 12-25 with high-prevalence mental illness and substance use recruited from headspace primary mental health centres in North-Western Melbourne. Self-report and interview measures of psychiatric diagnoses, symptoms, functioning, and substance use.
What this study cannot tell us
Small sample (n=79) with only 21 in the comparison group. Baseline cross-sectional data cannot establish causal direction. Recruited from a specific Melbourne region, limiting generalizability. Secondary analysis of trial data, not designed primarily for this comparison.
How to read the evidence
Baseline cross-sectional data from a small clinical trial provides preliminary evidence with limited generalizability due to sample size and single-region recruitment.
When this study was published
2025 publication; trial registered as ACTRN12619001522101
The bigger picture
The high overlap between substance use disorders and mental illness in young people supports integrated early intervention models. Treating either condition in isolation likely misses the compounding effects of comorbidity.
Questions still open
- Does early integrated treatment for co-occurring SUD and mental illness in youth prevent escalation of both conditions? Why did social functioning not differ between groups when other measures did?
Common questions
What was the difference between the two groups?
Did cannabis use specifically differentiate the groups?
Read the original research
Characteristics of Youth With Recent Substance Use With and Without Substance Use Disorder Presenting for Primary Mental Healthcare in Australia: Baseline Findings From the INTEGRATE Trial.
Early intervention in psychiatry, 19(12), e70106
Citation
Ahounbar, Ellie; Guerin, Alexandre A; Hides, Leanne; Bendall, Sarah; Chanen, Andrew; Clarke, Sarah; Quinn, Amelia; Baird, Shelley; Killackey, Eóin; McGorry, Patrick; Bedi, Gillinder. (2025). Characteristics of Youth With Recent Substance Use With and Without Substance Use Disorder Presenting for Primary Mental Healthcare in Australia: Baseline Findings From the INTEGRATE Trial.. Early intervention in psychiatry, 19(12), e70106. https://doi.org/10.1111/eip.70106
Explore the wider topic
- How to Talk to Your Teenager About Weed (Without Losing Them)
- My Kid's Friends Smoke Weed: A Parent's Guide
- I Smoke Weed But Don't Want My Kids To: Navigating the Hypocrisy
- Quitting Weed as a Parent: Why It Is the Hardest and Most Important Quit
- Quitting Weed as a Teen or Young Adult
- My Kid Is Smoking Weed: A Parent's Guide